Tolerability and effectiveness of albuvirtide combined with dolutegravir for hospitalized people living with HIV/AIDS

Treatment options for hospitalized people living with HIV/AIDS (PLWHA) with opportunistic infections and comorbidities are limited in China. Albuvirtide (ABT), a new peptide drug, is a long-acting HIV fusion inhibitor with limited drug-drug interactions and fast onset time. This single-center, retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Huanxia, He, Shenghua, Yang, Tongtong, Lu, Chunrong, Yao, Yuan, Zhou, Ruifeng, Yin, Ke, He, Yuanhong, Cheng, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4850
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637561/
https://www.ncbi.nlm.nih.gov/pubmed/37960773
http://dx.doi.org/10.1097/MD.0000000000035344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637561/
https://www.ncbi.nlm.nih.gov/pubmed/37960773
http://dx.doi.org/10.1097/MD.0000000000035344

Ejemplares similares